A homologous series of 1-alkyl-(N,N-dimethylamino)pyridinium bromides, termed compounds 1-11, was synthesized and studied for antibacterial and antifungal activity. Of these, compound 8, containing a ten-carbon alkyl chain, showed maximum inhibition against all the tested bacterial strains. The highest antibacterial activity using a disc diffusion method was recorded against Mycobacterium smegmatis [zone of inhibition (ZOI): 45.75±0.25 mm], followed by Escherichia coli, Proteus mirabilis, Vibrio cholerae, Staphylococcus aureus and Salmonella typhi. In addition to antibacterial activity, compounds 3-11 displayed good inhibitory action against the human opportunistic yeast pathogens Cryptococcus neoformans and various Candida spp. The maximum ZOI was observed against Cryptococcus neoformans (51.5±0.5 mm) using compound 8, with ZOIs of 23.5±0.5, 32.0±0.0, 27.75±0.25 and 41.5±0.5 mm against Candida albicans, Candida glabrata, Candida tropicalis and Candida krusei, respectively. Furthermore, compound 8 caused inhibition of the candidal yeast-hyphae transition at a concentration of 0.29 mM and also inhibited the secretion of extracellular hydrolytic enzyme such as secreted aspartyl proteinase at subinhibitory concentrations. Compound 8 showed very little haemolytic activity at a concentration of 0.58 mM (1.315±0.75 %), with its highest haemolytic activity (47.806±2.32 %) observed at a concentration of 2.9 mM.
INTRODUCTION
The emergence of bacterial and fungal resistance to antibiotics and an increase in the incidence of infections are important issues in drug development studies. Immunocompromised individuals such as patients infected by human immunodeficiency virus and those undertaking cancer chemotherapy and organ, blood and bone-marrow transplantation are more prone to invasive fungal infections, especially by Candida albicans and other nonalbicans Candida spp. These infections can be treated with known antifungals, but they show fungistatic rather than fungicidal effects. In addition, these drugs are often toxic to the host tissues. These circumstances warrant the development of new antimicrobials with high efficacy, low toxicity, a wide spectrum of activity and low costs and that are eco-friendly in nature (Denny et al., 2005; Ng et al., 2006; Rajeshkumar & Sundararaman, 2012) .
Quaternary ammonium compound salts containing long alkyl chains possess a wide range of antimicrobial activities against Gram-positive and Gram-negative bacterial pathogens and opportunistic fungal pathogens (Thorsteinsson et al., 2003; Zhao & Sun, 2008) and have been used for a variety of clinical purposes, including pre-operative disinfections, disinfection of non-critical surfaces, hard-surface cleaning and deodorization. Quaternary ammonium compounds are membrane-active substances and cause overall loss of structural organization and integrity of the cytoplasmic membrane in bacteria, together with other damaging effects to the bacterial cell (McDonnell & Russell, 1999) . They are generally considered to be toxic to mammalian cells and not suitable for systemic applications in therapeutics. However, pyridinium salts are quite stable and do not contain any phenol, iodine, active chlorine or mercury and other heavy metals (Madaan & Tyagi, 2008) , and hence are considered good candidates for further study and development.
A polar, positively charged nitrogen atom, stabilized by delocalization in the heterocylic pyridinium ring, an anionic counter-ion and a lipophilic polymethylene chain are the key structural elements of alkyl pyridinium salts and give rise to their polar lipid-like behaviour. This property is helpful in achieving binding to the cell wall and the active sites of enzymes, resulting in some interesting biological activities (Arning et al., 2008; Madaan & Tyagi, 2008) . N-Alkyl quaternary pyridinium salts can be prepared by simple, economical and short synthetic methods. Pyridinium salts, largely of synthetic origin, and some natural products (Timm et al., 2010) have been found to show good antimicrobial activity (Obando et al., 2009; Ilangovan et al., 2012) . Pyridinium succinate and acesulfamate showed good antimicrobial and insect deterrent activity (Hough-Troutman et al., 2009) . Interestingly, pyridinium salts with a long alkyl chain and sacchrinates can be fully mineralized (Neumann et al., 2010) .
1-Alkyl-4-(N,N-dimethylamino)pyridinium halides are a class of pyridinium salts that have found many applications such as phase-transfer catalysts in organic transformations (Kupetis et al., 2002) , surfactants (Gama et al., 1981) , liquid crystal display mediums (Ezaki & Kokeguchi, 2006) , ionic crystals for second-order non-linear optics (Anwar et al., 2001) , ionic liquids (Muldoon et al., 2010; Petkovic et al., 2011) and additives for protein refolding processes (Yamamoto et al., 2011) . However, there have been a limited number of studies on the biological activity of these compounds. Dimethylaminopyridine derivatives of lupane triterpenoids are potent disruptors of mitochondrial structure and function (Holy et al., 2010) . Similarly, tail-ended amphiphilic dimethylaminopyridinium-containing polymethacrylates have been found to be useful as gene delivery agents (Vuillaume et al., 2009) . The aminopyridinium groups are terminal moieties of the sidechain spacers containing 8, 12 or 16 methylene units. Polymethylene bis(4-dimethylaminopyridinium bromide) has also been found to be antimicrobially active (Sarkunam & Nallu, 2004) . Recently, we reported good antibacterial and antifungal activity of a series of 4-amino-1-alkylpyridinium bromides (Ilangovan et al., 2012) . In continuation of this work, here we have evaluated the antimicrobial properties, candidal virulence factor inhibition and haemolytic activity of a series of 1-alkyl-4-(N,N-dimethylamino)pyridinium bromides.
METHODS
Chemistry. Analytical-grade reagents and solvents were purchased from Sigma-Aldrich and Merck Chemicals. TLC was carried out on silica gel plates (Merck Chemicals) and the developed spots were located using UV (254 and 356 nm) and iodine. A mixture of chloroform : methanol (9 : 1, v/v) was used as the eluant. All melting points were uncorrected and measured using a Guna melting point apparatus. The compound in a capillary tube was heated slowly using a coil and the melting point was observed visually. 1 H-and 13 C-NMR spectra were obtained using a Brucker 400 MHz NMR spectrometer with tetramethylsilane as the internal standard. The samples were mixed with KBr and the pellet technique was adopted to record the spectra. Mass spectra were recorded on a Bruker-Daltons LC-MS spectrometer using a chemical ionization technique.
General procedure for the synthesis of 1-alkyl-4-(N,N-dimethylamino)pyridinium bromides (compounds 1-11). To a solution of 4-(N,N-dimethylamino)pyridine (10 mM) in acetone (dry, 20 ml), 1-n-bromoalkane (11 mM) was added and stirred at room temperature for 8 h. The 1-alkyl-4-(N,N-dimethylamino)pyridinium bromides precipitated as a white solid, which was filtered and washed with cold acetone (dry). The crude product was recrystallized using methanol. All the products were characterized by melting point, NMR, IR and mass spectral data.
Micro-organisms. The Gram-positive bacterial strains Staphylococcus aureus NCIM 5021, Salmonella typhimurium MTCC 3917, Mycobacterium smegmatis (National Institute of Research in Tuberculosis, Chennai, India) and Gram-negative bacterial strains Escherichia coli NCIM 2065, Vibrio cholerae MTCC 3904, Proteus mirabilis MTCC 425, the four Candida species of Candida albicans NCIM 3471, Candida glabrata NCIM 3236, Candida tropicalis NCIM 3118 and Candida krusei NCIM 3129, and Cryptococcus neoformans NCIM 3542 were used for the study of antimicrobial screening. The organisms were maintained on agar slants, subcultured periodically and stored at 4 uC. Prior to any test, the organisms were activated at 37 uC for 24 h on nutrient agar or Sabouraud dextrose agar (HiMedia Laboratories) for the bacterial and fungal strains, respectively.
Antimicrobial activity
Disc diffusion method. Antimicrobial tests were carried out primarily by the disc diffusion method as described by Bauer et al., (1966) . Both bacterial and opportunistic pathogenic yeast inocula were prepared from 18 h cultures (~10 4 -10 6 cells ml 21 ). Petri dishes containing the bacterial and yeast inocula in nutrient agar and Sabouraud dextrose agar, respectively, were used for the study. All the compounds were dissolved in sterile distilled water and 10 ml was loaded onto sterile filter paper discs (6 mm diameter) at a final concentration of 500 mg per disc. The plates were then incubated at 37 uC for 24 h and the zone of inhibition (ZOI) was measured.
Broth macrodilution method. The MIC, minimal bactericidal concentration (MBC) and minimal fungicidal concentration (MFC) were evaluated for compound 8, to determine the lowest concentration of compound that inhibited visible growth (MIC) and the bactericidal and fungicidal effects against the tested strains. The reference strains of E. coli and Candida albicans were used to determine the inhibitory concentrations of the compound: 10 ml of a mid-exponential culture (1610 6 cells ml
21
) was seeded with compound 8 at concentrations of 0.29-14.5 mM in 1 ml total volume of nutrient broth or Sabouraud dextrose broth for bacteria and fungi, respectively, and incubated at 37 uC for 24 h with gentle agitation. After incubation, the culture pellets were obtained by centrifugation (REMI Cooling Centrifuge 24 BL), resuspended in 0.1 ml culture broth and the whole suspension was swabbed onto the respective agar plates and allowed to incubate for a further 24-48 h at 37 uC (CLSI, 2006 (CLSI, , 2008 .
Germ-tube inhibition. A serially diluted solution of compound 8 ranging from 2.9 mM to 57 nM was used to determine the inhibition of germ-tube formation by the yeast opportunistic pathogen Candida albicans. Germ-tube inhibition was undertaken using the method of Ellepola & Samaranayake (1998) with some modifications. Assay medium (1 ml) consisting of yeast nitrogen (HiMedia Laboratories; prepared following the manufacturer's instructions) in base broth and the serially diluted test compound was incubated with a single colony of an overnight-grown culture of Candida albicans and the tubes were incubated at 37 uC for 3-4 h. After incubation, the cells were placed on microslides and observed under a light microscope to evaluate the development or inhibition of germ tubes. 74 mM) of the test compound was inoculated with 100 ml Candida albicans culture (1610 6 cells ml 21 ) and incubated at 37 uC for 48 h with shaking at 80 r.p.m. Distilled water was used as a control. To perform the proteinase inhibition, 0.1 ml culture supernatant was added to 0.9 ml medium containing 0.1 M citrate buffer (pH 3.2) and 0.2 % (w/v) BSA, and incubated at 37 uC for 1 h. The reaction was stopped by adding 1 ml 5 % (w/v) ice-cold TCA. The mixture was centrifuged at 1500 g for 10 min and the absorbance of the supernatant was read at 280 nm on a UV Visible Spectrophotometer 119 (Systronics).
Phospholipase inhibition. To evaluate phospholipase inhibition, compound 8 was used against the opportunistic yeast pathogen Candida albicans (Samaranayake et al., 1984) . Candida albicans was used as a positive control for phospholipase secretion and Candida glabrata served as negative control. The strains were grown in Sabouraud dextrose broth. Compound 8 (1 ml) at concentrations of 0.56, 16(1.74 mM), 26 and 46 MIC in PBS and 250 ml Candida albicans or Candida glabrata culture (1610 8 cells ml 21 ) were mixed and incubated for 30 min at 37 uC with gentle shaking. After incubation, the culture was centrifuged at 2000 g for 10 min and the supernatant discarded. The pellet was washed three times with PBS to remove residual antifungal agent, resuspended in 100 ml PBS and 10 ml (~10 7 cells ml 21 ) was plated on egg-yolk-containing phospholipase-inducing medium [10 g peptone, 30 g glucose, 57.3 g NaCl, 0.55 g CaCl 3 , 15 g agar, 8 % (v/v) egg yolk made up to 1 l with distilled H 2 O]. The plates were incubated for 3 days at 37 uC to observe phospholipase inhibition. The zone of precipitation (P3) was measured and the percentage inhibition was calculated by comparing treated and untreated culture plates (Kadir et al., 2007) .
Haemolytic assay. The haemolytic activity of compound 8 against human red blood cells was evaluated according to the method of Obando et al. (2009) . The test solution containing 0.5 ml cell suspension in PBS (final erythrocyte concentration~0.5610 9 cells ml 21 ) was mixed with 0.5 ml compound 8, prepared from a stock solution to give final concentrations of 0.58, 1.16, 1.74, 2.32 and 2.9 mM. The mixture was incubated at 37 uC for 1 h with gentle shaking, followed by centrifugation at 2000 g for 10 min. The supernatant was diluted tenfold with PBS, and optical density was measured at 540 nm. The values for 0 and 100 % lysis were determined by incubating cells with PBS or 0.1 % (w/v) Triton X-100 (in water), respectively.
Statistical analysis. All experiments were carried out in triplicate to allow statistically valid conclusions. The results are expressed as means±SEM.
RESULTS AND DISCUSSION
Synthesis of 1-alkyl-(N,Ndimethylamino)pyridinium bromides
Methods for the preparation of some 1-alkyl-(N,Ndimethylamino)pyridinium bromides via a quaternization reaction of the alkyl halide with 4-dimethylaminopyridine in solvents such as 2-propanol, dioxane and acetone have been described previously in the literature. A homologous series of 1-alkyl-(N,N-dimethylamino)pyridinium bromides was prepared by adopting a procedure that has been used previously by us for the synthesis of 1-alkyl-4-aminopyridinium bromides (Ilangovan et al., 2012) . Accordingly, a mixture of 4-N,N-dimethylaminopyridine (1 equiv.) and 1-bromo-n-alkyl halides (1.1 equiv.) in acetone (dry) was refluxed for 6-10 h to get the desired quaternary 1-alkyl-4-(N,N-dimethylamino)pyridinium bromide salts (termed compounds 1-11) in high yields of 90-95 % (Figs 1 and 2 ). All the products were obtained as white solids after washing with cold acetone and drying under vacuum, and were characterized by melting point, IR and 1 H-and 13 C-NMR mass spectral analysis. The lipophilic character of these compounds increased with the increase in number of methylene groups in the alkyl chain. The solubility in polar solvents such as DMSO and water decreased as the carbon chain length increased.
Antibacterial activity
Compounds 1-11 were screened for their antibacterial activity against Gram-positive and Gram-negative strains of human pathogenic bacteria. Preliminary screening for antibacterial activity was carried out using the method described by Bauer et al. (1966) . Compounds 1 and 2 did not show significant activity and were highly hygroscopic in nature; consequently, these compounds were not considered further. Interestingly, from compound 3 to compound 8, there was a gradual increase in efficiency observed against all the bacterial strains tested (Table 1) . In contrast, compounds 9-11 showed a trend of decreasing activity, which may have been due to the poor solubility of these compounds in the culture medium used for the study. Thus, the antimicrobial activity was parabolically related to the length of the alkyl chain of the compounds used in this study (Kabara, 1978; Zhao & Sun, 2008 ).
Of all the tested compounds, compound 8 showed the maximum inhibition against all the tested bacterial strains. The highest antibacterial activity was recorded against M. smegmatis (ZOI: 45.75±0.25 mm) followed by E. coli, P. mirabilis, V. cholerae, Staphylococcus aureus and Salmonella typhi at the tested concentration (500 mg per disc), followed by compound 9. As compound 8 showed the highest inhibition levels against all the pathogens tested, this compound was chosen to determine the MBC. Compound 8 was serially diluted from 14.5 to 0.29 mM and MIC and MBC values were determined under the appropriate medium and incubation conditions. At a concentration of 0.87 mM, there was no observable turbidity in the medium when compared with untreated tubes, and this value was considered the MIC of compound 8. The cells were washed with PBS to remove the suspended compounds, and pellets were collected and resuspended in 0.1 ml nutrient broth. This solution was plated on nutrient agar using the spread plate technique and incubated at 37 u C for 24 h for viable count analysis. The results showed that the MBC of the compound 8 was 1.16 mM as tested on the reference E. coli strain. The mechanism of antibacterial action of these compounds could be attributed to any of its IP: 54.70.40.11
On: Wed, 12 Dec 2018 13:10:48 known actions such as perturbing the bacterial lipid bilayer membrane (Zhao & Sun, 2008) , alteration in cell structure, interference with the respiration or glycolysis of the microorganisms, and inhibition of the oxidative system (Madaan & Tyagi, 2008) .
Antifungal activity
In addition to antibacterial activity, compounds 3-11 were screened for inhibitory action against human opportunistic pathogen Candida spp. and Cryptococcus neoformans using a disc diffusion method. Compounds 3-11 were used to determine growth inhibition at a concentration of 500 mg per disc. Compounds 3 and 4 did not inhibit the tested Candida strains significantly, although a ZOI was observed (7±0 and 13±0 mm, respectively) against Candida glabrata.
Like the antibacterial activity, there was a gradual increase in the antifungal activity, shown by the size of the ZOI, against all the pathogens screened for compounds 3-8, but for compounds 9-11, the size of the zone of inhibition gradually decreased, again probably due to the lower solubility of these compounds. As with the antibacterial activity, compound 8 showed the highest levels of inhibition against all the yeast pathogens. The maximum ZOI (51.5±0.5 mm) was observed against Cryptococcus neoformans, with ZOIs of 23.5±0.5, 32.0±0.0, 27.75± 0.25 and 41.5±0.5 mm against Candida albicans, Candida glabrata, Candida tropicalis and Candida krusei, respectively (Table 2) . Based on the higher activity displayed by compound 8, it was selected for further studies and the MIC was evaluated. Compound 8 inhibited visible growth of the reference yeast strain Candida albicans at a concentration of 1.74 mM. The viable count was also measured to determine the MFC and the compound was found to show a total fungicidal effect at a concentration of 2.9 mM. Thus, compared with the antibacterial activity, a higher concentration of compound 8 was required to inhibit the yeast cells. This weaker antifungal activity could be attributable to a different mode of action, as the antibacterial activity could be achieved by several mechanisms including the destruction of membranes, but, in the case of antifungal activity, the compound acts only on the fungal respiratory system rather than on cell membranes (Alptüzün et al., 2009) . Specifically, the antifungal activity could be attributable to a cascade of reactions including inhibition of cell-wall permeability and mitochondrial respiration. Consequently, it could lead to inhibition of Sap secretion, germ-tube production and cell lysis. To understand further the mode of action, a detailed study on structure-activity relationships needs to be carried out.
Germ-tube inhibition Candida albicans is a dimorphic fungus that can switch from a budding yeast to hyphae to produce invasive fungal infections. The pseudohyphal or hyphal form of this opportunistic yeast pathogen is considered the more virulent, as it expresses host-specific surface proteins enabling it to invade host tissues, interrupt M. Sundararaman and others the host immune system and escape host phagocytosis (Fábry et al., 1999) . Hence, germ-tube inhibition is a possible mechanism of controlling infections. Compound 8 was chosen based on its higher anticandidal activity. The compound 8 was serially diluted from 2.9 mM to 57 nM, added to 1 ml test solution in a sterile culture tube and incubated at 37 u C for 3-4 h for the development of hyphae. At every 1 h interval, a loop of culture was withdrawn from the test solution and observed under a light microscope (406 magnification) for the growth or inhibition of germ tubes. At concentrations between 57 nM and 0.228 mM, pseudohyphae production was observed but at a concentration of 0.29 mM, there was complete inhibition of germ-tube production. Thus, the strong anticandidal activity of this 1-alkyl-4-(N, N-dimethylamino)pyridinium bromide salt appeared to be at least partly the result of germ-tube inhibition at very low concentration. As such, there is the potential for its use as an oral mouthwash or antiseptic, after the completion of detailed toxicity studies.
Effect of compound 8 on Sap and phospholipase activity Extracellular hydrolytic enzymes such as Sap and phospholipase are factors for determining the virulence of Candida albicans and other non-albicans Candida spp. These enzymes contribute to the ability of these opportunistic pathogens to invade host tissues by digesting and destroying cell membranes for nutrients, and also by attacking cells and molecules responsible for host immune system such as Igs and other proteins (Schaller et al. 2005; Costa et al., 2010) . Based on the highest anticandidal activity, compound 8 was used to study its inhibitory activity against the Candida albicans extracellular enzymes Sap and phospholipase. To study Sap inhibition, Candida albicans proteinase activity was measured spectrophotometrically after 48 h of incubation (Fig. 3) . Maximum activity was observed in control cells without treatment with any inhibitor. Cells treated with pepstatin A, a known proteinase inhibitor, showed decreased levels of Candida albicans proteinase activity, with~72 % of Sap production inhibited, in agreement with the results of a previous study (Schaller et al., 2003) . The assay was also performed with the standard antifungal agent amphotericin B (at 5 and 10 mg ml 21 ); there was no significant reduction in proteinase activity at the concentration of 5 mg ml
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. The proteolytic activity of Candida albicans was determined at subinhibitory MICs (0.256 and 0.56) and at 16 MIC of compound 8. The results showed a gradual decrease in Sap activity, with the highest proteolytic activity observed at a concentration of 1.74 mM (16 MIC; Fig. 3 ). The viability of cells was confirmed before the proteolytic activity assay by the plating method. Compound 8 did not show any significant activity (data not shown) on phospholipase inhibition at the tested concentrations, and these results correlated with a previous study by Lyon et al., (2011) using different surfactant molecules such as cetyltrimethylammonium chloride, SDS, N-hexadecyl-N-N-dimethyl-3-ammonio-1-propane-sulfonate and Triton X-100.
Haemolytic activity
Assessment of the cytotoxic nature of compounds using an in vitro haemolytic assay is a simple tool to measure the equivalent activity of in vivo toxicity towards host cells (Sayes et al., 2007) . As the structures of the compounds are similar to bolaform surfactants, it is likely that they have a simple lytic mode of action and will be broadly cytotoxic against human cells (Obando et al., 2009) . As compound 8 exhibited strong antimicrobial candidal yeast-hyphae transition and Sap inhibition, it could be developed further as an antimicrobial therapeutic. The compound was serially diluted from 2.9 to 0.58 mM and tested for its haemolytic activity. A very low haemolytic activity was observed at 0.58 mM (1.32±0.75 %), with the highest haemolytic activity (47.81±2.32 %) observed at a concentration of 2.9 mM (Fig. 4) . The antifungal agent amphotericin B was also used to determine the haemolytic activity and showed complete haemolysis at a concentration of ,1.08 mM (results not shown). The maximum concentrations of compound 8, 1.16 and 2.9 mM, were required to achieve the MBC against E. coli and the MFC against Candida albicans, respectively. However, a high (47.81± 2.32 %) level of haemolysis was observed at the concentration of 2.9 mM, although a low (1.32±0.75 %) level of haemolysis was observed at 0.58 mM. This result demonstrated that the compound 8 showed good antimicrobial activity and low toxicity to human red blood cells. Hence, it is suggested that the absence of or low level of haemolytic activity can be assumed to be the result of the absence of cytotoxic action, and this finding correlates with a previous report on 4-amino-1-alkyl pyridinium salts (Ilangovan et al., 2012) .
Conclusion
A homologous series of 1-alkyl-(N,N-dimethylamino)pyridinium bromides with carbon chain length varying from 2 to 16 was studied for antimicrobial activity against Grampositive and Gram-negative bacterial pathogens including Salmonella typhimurium and Vibrio cholerae and for anticandidal activity against Candida albicans and other non-albicans Candida spp. The antimicrobial activity increased gradually from compound 3 to compound 8, and then decreased from compound 9 to compound 11, denoting a parabolic relationship with the length of the alkyl chain and agreeing with previous reports (Kabara, 1978; Zhao & Sun, 2008) . Compound 8 achieved excellent antifungal activity and inhibited germ-tube formation and extracellular enzyme production such as Sap of Candida albicans at very low concentrations (0.29 and 1.74 mM, respectively). Compound 8 did not show any significant activity of phospholipase inhibition at the tested concentrations. The 1-dodecyl-(N, N-dimethylamino)pyridinium bromides displayed minimal cytotoxicity against human red blood cells compared with the well-known antifungal agent amphotericin B. Interesting aspects of this class of compounds such as the simple preparation procedure, the low cost involved in preparation, good antibacterial and antifungal activity and low haemolytic activity compared with known antifungal agents make this compound promising as a new class of potential antimicrobial agent.
